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ER–TGN contact sites (ERTGoCS) have been visualized by electron microscopy, but their location in the crowded perinuclear 
area has hampered their analysis via optical microscopy as well as their mechanistic study. To overcome these limits we 
developed a FRET-based approach and screened several candidates to search for molecular determinants of the ERTGoCS. 
These included the ER membrane proteins VAPA and VAPB and lipid transfer proteins possessing dual (ER and TGN) targeting 
motifs that have been hypothesized to contribute to the maintenance of ERTGoCS, such as the ceramide transfer protein 
CERT and several members of the oxysterol binding proteins. We found that VAP proteins, OSBP1, ORP9, and ORP10 are 
required, with OSBP1 playing a redundant role with ORP9, which does not involve its lipid transfer activity, and ORP10 being 
required due to its ability to transfer phosphatidylserine to the TGN. Our results indicate that both structural tethers and a 
proper lipid composition are needed for ERTGoCS integrity.
Molecular determinants of ER–Golgi contacts 
identified through a new FRET–FLIM system
Rossella Venditti1,2*, Laura Rita Rega1*, Maria Chiara Masone1, Michele Santoro1, Elena Polishchuk1, Daniela Sarnataro2, Simona Paladino2, 
Sabato D’Auria3, Antonio Varriale3, Vesa M. Olkkonen4,5, Giuseppe Di Tullio1, Roman Polishchuk1, and Maria Antonietta De Matteis1,2
Introduction
Membrane contact sites (MCSs) are sites of close apposition 
(10–20 nm) between two distinct organelles where the ex-
change of solutes or lipids occurs between the facing organelles. 
The ER is involved in forming most (though not all) MCSs with 
other organelles including mitochondria, the plasma membrane 
(PM), endosomes, lysosomes, and the Golgi complex (Murley 
and Nunnari, 2016; Phillips and Voeltz, 2016). These structures 
have attracted considerable attention in recent years, and sev-
eral tethering complexes have been identified that mediate the 
coupling of the apposing organelles (Eisenberg-Bord et al., 2016). 
The ER–TGN contact sites (ERTGoCS) are the least well defined 
(De Matteis and Rega, 2015), despite the fact that sites of close 
apposition between the ER and the last trans cisterna/trans-Golgi 
network (herein collectively called TGN) have been documented 
by ultrastructural analysis since the early 1960s (Novikoff, 1964; 
Rambourg et al., 1979; Ladinsky et al., 1999). This is partly due to 
the position of the Golgi complex in the crowded perinuclear area 
that has hampered the analysis of these MCSs by optical micros-
copy due to the resolution limits of this approach. There is thus a 
dearth of knowledge regarding fundamental aspects of ERTGoCS 
such as their frequency, regulation, and composition. These gaps 
in our knowledge about ERTGoCS, mainly due to methodological 
limits, have hampered direct studies to address this question. 
We therefore developed a Förster resonance energy transfer 
(FRET)–based approach (Grecco and Bastiaens, 2013), which is 
endowed with the necessary nanoscale resolution power for the 
study of ERTGoCS.
Results
Morphometric analysis of ERTGoCS
We initially performed a morphometric ultrastructural analysis 
and found that 55–60% of Golgi stacks are engaged in MCSs (de-
fined as areas where the distance between the TGN and the ER 
membranes is ≤20 nm) with the ER with a distance ranging from 
5 to 20 nm (average, 12 nm), a mean length of 176 nm, and a mean 
occupancy of 24% of the TGN surface area (Fig. 1, A–C). A 3D view 
of the ERTGoCS using focused ion beam–scanning electron mi-
croscopy (FIB-SEM) showed that the ER is closely apposed to the 
TGN occluding a surface area of up to 0.2 µm2 for each organelle 
(Fig. 1 D and Video 1).
ERTGoCS can be visualized by FRET–fluorescence lifetime 
imaging microscopy (FLIM)
We next developed a FRET-based approach that involves a 
donor fluorophore molecule (GFP) conjugated to a TGN mem-
brane protein (TGN46) that, when excited, transfers energy 
to an acceptor fluorophore molecule (mCherry) conjugated 
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to an ER membrane protein (the C tail of cytochrome b5, Cb5) 
provided that the two fluorophores are within a distance of 
1–10 nm (Fig. 2, A and B; and Materials and methods; Grecco 
and Bastiaens, 2013). In the presence of FRET phenomenon, the 
lifetime of the donor becomes shorter, as a consequence of the 
process of energy transfer to the acceptor molecule. Thus, in 
our assay we used FLIM of cells expressing TGN46-GFP alone or 
TGN46-GFP and mCherry-Cb5 at equimolar amounts (Fig. 2 A 
and Materials and methods). The mean fluorescence lifetime 
(τ, in nanoseconds) of the TGN46-GFP donor protein was mea-
sured by FLIM in defined regions of interest (ROIs; Fig. 2 C and 
Materials and methods). A clear decrease of the TGN46-GFP 
mean τ value was detected in cells expressing TGN46-GFP/
mCherry-Cb5 compared with cells expressing TGN46-GFP 
alone or together with cytosolic, free mCherry (Fig. 2, D and E). 
The FRET efficiency was calculated for each pixel of the ROI, 
and the spatial FRET distribution was depicted using pseudo-
colors (Fig. 2 F). A heterogeneous FRET efficiency map was ap-
parent with hot spots likely corresponding to a single ERTGoCS. 
The FRET signal was abolished by photobleaching the acceptor 
fluorophore while it was increased using longer helical linkers 
(Várnai et al., 2007) between the fluorophores and the TGN and 
ER membrane proteins (Fig. S1, A and B). A FRET–FLIM signal 
(with an average FRET efficiency of 0.2) was also measured 
using a different donor fluorophore molecule (Alexa Fluor 430 
conjugated to anti-HA antibodies) together with the mCherry 
acceptor molecule in cells expressing TGN46-HA/mCherry-Cb5 
(Fig. S1, C–F).
We tested the FRET-based assay under conditions that have 
been hypothesized to destabilize ERTGoCS or to artificially in-
duce them (Peretti et al., 2008; Mesmin et al., 2013). To destabi-
lize ERTGoCS, cells were depleted of the VAP proteins (VAPA and 
VAPB), ER integral membrane proteins that are involved in differ-
ent classes of contact sites (Murphy and Levine, 2016), by siRNA 
treatment or by transcription activator-like effector nuclease 
(TAL EN; Dong et al., 2016). Ultrastructural analyses showed the 
disruption of almost all ERTGoCS, with <10% of the Golgi stacks in 
VAP-KD cells having an MCS with the ER (Fig. 3 A). Concordantly, 
the FLIM analysis showed a decreased FRET efficiency of the ER/
TGN pair of reporter proteins (with an increase in lifetime of the 
donor) in VAP-KD and VAP-KO cells as compared with control 
cells (Fig. 3, B and C; and Fig. S1, E and F). By contrast, the FRET 
efficiency of the ER/TGN pair of reporter proteins increased sig-
nificantly (and the lifetime value of the donor decreased) under 
two independent conditions that stabilize ERTGoCS (Fig. 3, B, 
D, and E). The first involved the expression of the recombinant 
protein PH-FFAT (Mesmin et al., 2013) that can bridge the TGN 
and the ER since it contains a Golgi targeting motif, represented 
by a PH domain that binds PI4P (the phosphoinositide enriched 
at the TGN), and an ER targeting motif represented by a FFAT 
Figure 1. Morphometric analysis of ERTGoCS. (A) Electron micrograph showing ER (white arrowhead) closely apposed (red dashed line) to the TGN (black 
arrowheads) in a HeLa cell expressing TGN46-HRP (visualized by the DAB reaction that produces a dark product in the lumen of the TGN). Golgi cis elements are 
indicated. (B) Measurement of ERTGoCS distance (left; y axis) and length (right; y axis). Mean ± SD of 40 and 22 Golgi stacks, respectively, representative of three 
independent experiments. (C) Percentage of Golgi stacks negative (white bar) or positive (black bar) for ERTGoCS (left part of graph). In the ERTGoCS-positive 
Golgi stacks, the frequency distribution of the ERTGoCS surface area was calculated and expressed as a percentage of the total TGN surface (Materials and 
methods). n = 130 Golgi stacks. (D) FIB-SEM images of a HepG2 cell. Four images from Video 1 taken every 60 nm representing a total depth of 240 nm. The ER 
is colored in red and the TGN in green. The small arrow indicates a clathrin-coated profile that identifies the trans pole of the Golgi.
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motif that binds the VAP proteins in the ER (Murphy and Levine, 
2016; Fig. 3, B and E). The second was the chemically induced 
dimerization of the TGN46 and Cb5 reporter proteins fused with 
FRB and FKB domains (Choi et al., 1996) by short treatment with 
low concentrations of rapamycin (200 nM for 2 min; Fig. 2, A and 
B; and Fig. 3, B and D).
ORP10 is required to maintain the ERTGoCS, while OSBP1 and 
ORP9 have a redundant role
Having validated our FRET–FLIM strategy and with a suitable 
positive control (i.e., VAP depletion), we performed an siRNA- 
based search for components of ERTGoCS in cells expressing 
TGN46-GFP and mCherry-Cb5. We explored the role of proteins 
that have been proposed as candidate tethering factors between 
the ER and the Golgi since they possess dual targeting motifs for 
the two organelles, i.e., a FFAT (FFAT-like motif or putative FFAT 
motif) and a PI4P-binding PH domain. These proteins included 
OSBP1 and members of the oxysterol-binding protein-related 
protein (ORP) family that localize at the Golgi complex (ORP9, 
ORP10, and ORP11); the ceramide transfer protein CERT; and the 
FAPP proteins, FAPP1 and FAPP2 (Hanada et al., 2003; D’Angelo 
et al., 2007; De Matteis et al., 2007; Ngo and Ridgway, 2009; 
Mikitova and Levine, 2012; Nissilä et al., 2012; Weber-Boyvat et 
al., 2015; Fig. 4 A). Of note, all the tested proteins, except FAPP1, 
Figure 2. FRET–FLIM analysis of ERTGoCS. (A) Schematic representation of the TGN (TGN46-GFP; top construct) and ER (C tail of CytB5, Cb5; bottom con-
struct) membrane reporter proteins used in this study (see Materials and methods for a detailed description of individual domains). (B) Graphic representation 
of the topology of the donor (TGN46-GFP) and the acceptor (mCherry-Cb5) fluorophores at the ERTGoCS under different conditions: left, normal-length linkers 
(16 amino acids used in the majority of the experiments; Várnai et al., 2007); middle, longer helical linkers (61 amino acids; Várnai et al., 2007); and right, 2 min 
treatment with 200 nM rapamycin. The mean FRET efficiency measured in the ROI is indicated for each condition. (C) The FLIM showing donor (TGN46-GFP) 
mean lifetime in the presence of the acceptor (mCherry-Cb5) in a defined ROI (top) compared with the whole TGN area (bottom) in cells expressing reporter 
proteins with normal-length linkers. The τ values are represented by a pseudocolor scale ranging from 1.8 to 2.5 ns. (D) FLIM (in color) and immunofluorescence 
(IF; gray) images of HeLa cells expressing the TGN46-GFP (donor) alone (top), TGN46-GFP and mCherry-Cb5 (donor+acceptor; middle), or TGN46-GFP with 
free cytosolic mCherry (bottom). The FLIM images show the spatial variation of the mean fluorescence lifetime (τ) of TGN46-GFP: τ values are represented by 
a pseudocolor scale ranging from 1.8 to 2.5 ns. (E) Mean τ value distribution curves of TGN46-GFP (donor) in cells expressing TGN46-GFP alone (top; red line), 
TGN46-GFP and mCherry-Cb5 (middle; green line), or TGN46-GFP with free mCherry (bottom; orange line). (F) The spatial distribution of the FRET efficiency 
(FRET [%] map) is depicted (color scale ranges from 0 to 30%).
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also possess a lipid transfer domain with a distinct lipid speci-
ficity. To our surprise, only one (ORP10) out of the entire set of 
candidates tested affected the stability of the ERTGoCS when 
depleted. In fact, the mean lifetime of TGN46-GFP in ORP10- 
depleted cells expressing TGN46-GFP and mCherry-Cb5 was not 
significantly different from that measured in cells expressing 
TGN46-GFP alone, and consequently, the FRET efficiency was 
extremely low in ORP10-depleted cells as compared with control 
cells (Fig. 4, B and C). We then combined depletion of two candi-
dates at a time, driven by the hypothesis that the depletion of one 
component might be compensated by another protein with sim-
ilar activity (Eisenberg-Bord et al., 2016). We found that except 
for the depletions involving ORP10, only the combined depletion 
of OSBP1 and ORP9 was able to significantly affect ERTGoCS 
stability (Fig. 4, B and D). Importantly, the results obtained by 
FRET–FLIM measurements were validated by ultrastructural 
and stereological analyses that showed that the only conditions 
that affected the ERTGoCS organization were ORP10 depletion 
and the combined depletion of OSBP1 and ORP9 (Fig. 4, E and F; 
and Fig. S2, A and B).
ORP10 is required to maintain the ERTGoCS due to its ability 
to transfer phosphatidylserine (PS)
We next investigated the molecular mechanisms underlying the 
requirement of the identified hits in sustaining the ERTGoCS and 
in particular whether this was dependent on their lipid trans-
fer activity. ORP10 associates with microtubules but also with 
the Golgi complex (Fig. 5 A; Nissilä et al., 2012), and while not 
possessing a canonical FFAT domain, it can interact with VAPs 
(Weber-Boyvat et al., 2015; Murphy and Levine, 2016). ORP10 
belongs to the ORP subfamily that includes members that can 
transfer PS (Maeda et al., 2013), such as ORP5 and ORP8 that 
transfer PS in exchange for PI4P between the ER and the PM 
(Chung et al., 2015), while ORP10 itself has been shown to bind 
and extract PS (Maeda et al., 2013). We observed that the resi-
dues of the oxysterol-related domain (ORD) of ORP5/ORP8 that 
are involved in PS/PI4P exchange (Chung et al., 2015) are very 
well conserved in ORP10 (Fig. 5 B). To investigate whether the 
requirement for ORP10 in maintaining the ERTGoCS is due to a 
structural role or to its lipid transfer activity, siRNA-resistant 
ORP10 was reexpressed in ORP10-depleted cells, both in its WT 
Figure 3. The VAPs are required to establish/maintain the ERTGoCS. (A) Electron micrograph of a VAP-KD cell and quantification of ERTGoCS in WT and 
VAP-KD cells. n = 40 Golgi stacks. (B) Quantification of average donor lifetime in donor alone or donor+acceptor VAP-KD and VAP-KO HeLa cells, in cells after 
treatment with rapamycin (2 min, 200 nM), or after transfection with FLAG-tagged PH-FFAT of OSBP1. The corresponding FRET efficiency is shown on the 
right. n = 20; data are means ± SD. **, P < 0.01; ***, P < 0.001; Student’s t test. (C–E) Representative immunofluorescence (IF; gray) and FLIM (in color) images 
showing donor lifetime in VAP-KD and VAP-KO cells (C), in rapamycin-treated cells (D), and in PH-FFAT–expressing cells (E). The pseudocolor scale representing 
the τ values of TGN46-GFP is the same as in Fig. 2 D. The graphs show the mean τ value distribution curves of TGN46-GFP under the indicated conditions.
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form and in forms where the ORD sites involved in PS (L418D) 
and PI4P (H535/536A) binding had been mutated (Fig. 5 B). We 
found that the WT but not the mutant forms of ORP10, which 
were correctly targeted to the Golgi complex (Fig. 5 C), could re-
establish ERTGoCS in ORP10-depleted cells (Fig. 5 D and Fig. S3, 
A and B), indicating that the lipid transfer activity of ORP10 is 
required for the stability of these MCSs. PS is synthesized in the 
ER but is enriched in the PM, the TGN, and endosomes (Leventis 
and Grinstein, 2010; Fairn et al., 2011), where it is asymmetrically 
distributed between the bilayer leaflets, being confined to the cy-
tosolic leaflet. Thus, we tested the possibility that ORP10 might 
be involved in transferring PS from the ER to the cytosolic leaflet 
of TGN membranes by studying the effect of ORP10 depletion on 
the subcellular distribution of PS using two distinct genetically 
Figure 4. ORP10 has an essential role, while OSBP and ORP9 play a redundant role in establishing/maintaining the ERTGoCS. (A) Graphical represen-
tation of the candidate proteins analyzed in the siRNA-based screen. The candidates possess a Golgi targeting motif represented by a PI4P-binding PH domain 
and an ER targeting motif represented by a FFAT motif (OSBP, ORP9, and CERT; Murphy and Levine, 2016) or a putative FFAT-like motif (FAPP2 [Mikitova and 
Levine, 2012] and ORP10 and ORP11 [Murphy and Levine, 2016]) that mediates the interaction with the VAP ER membrane proteins. FAPP1 possesses two 
potential FFAT motifs: 165 TFI TTLE 171 (if phosphorylated on T165 and T168) and 242 TYS DTDS 248 (if phosphorylated on T242 and S248). (B) FLIM images of 
HeLa cells expressing TGN46-GFP and mCherry-Cb5 (donor+acceptor) transfected with the indicated siRNAs. The τ values are represented by a pseudocolor 
scale ranging from 1.8 to 2.5. Scale bar, 10 µm. (C and D) Quantification of average TGN-GFP lifetime in HeLa cells expressing TGN46-GFP and mCherry-Cb5 
(donor+acceptor) and transfected with the indicated single (C) or combined (D) siRNAs. Donor indicates cells transfected with TGN46-GFP alone; CTRL indicates 
cells transfected with nontargeting siRNAs. The corresponding FRET efficiency is shown on the right. n = 20; data are means ± SD. *, P < 0.05; **, P < 0.01; 
Student’s t test. (E) Electron micrographs of ORP10-KD, OSBP1-KD, ORP9-KD, and OSBP1+ORP9-KD cells. (F) Corresponding quantification of the percentage 
of Golgi stacks engaged in ERTGoCS (ERTGoCS occurrence). n = 20–30 Golgi stacks. Scale bar, 200 nm.
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encoded probes: the PS binding domain of lactadherin (C2 do-
main; Yeung et al., 2008; Fig. 5 E) and of evectin (PH domain; 
Uchida et al., 2011; Fig. S3 C). We found that ORP10 depletion in-
duced a decrease in PS at the Golgi as evaluated by the distribu-
tion of the two PS probes (Fig. 5 E and Fig. S3 C), which showed 
a marked reduction of the Golgi pool (but not of the PM pool) 
in ORP10-KD cells, and by the observation that a lower amount 
of TGN membranes from ORP10-KD cells was retained on PS- 
affinity beads as compared with control cells (Fig. S3 D).
Thus, ORP10 is required to safeguard the PS content in the 
TGN and, at the same time, the ERTGoCS (Fig. 4, A–F; Fig. 5 E; and 
Fig. S3, C and D), indicating that the lipid composition of the TGN, 
and in particular its PS content, is of crucial importance for the 
establishment/maintenance of these structures. Supporting this 
hypothesis, exogenous supplementation of PS partially restored 
ERTGoCS in ORP10-depleted cells (Fig. 5 F). Similar results were 
obtained when the production of PS was boosted through the 
overexpression of a mutant (P269S) form of PS synthase 1 that is 
Figure 5. The integrity of the ERTGoCS requires the PS transfer activity of ORP10. (A) Subcellular localization of mCherry-tagged WT-ORP10 and of the 
Golgi marker Golgin-97. Scale bar, 10 µm. (B) Residues in ORP5/ORP8 involved in PS/PI4P exchange are conserved in the ORP10 ORD domain. (C) Subcellular 
localization of ORD-domain mutant forms (L418D and H535/536A) of mCherry-tagged ORP10. Scale bar, 10 µm. (D) Quantification of ERTGoCS in WT and 
ORP10-KD cells and in ORP10-KD cells expressing siRNA-resistant GFP-tagged WT-ORP10 or ORD-domain mutant forms of ORP10. The experiment was 
performed in HeLa cells stably expressing the TGN46-FRB-HA and mCherry-T2A-FKBP-Cb5 reporter proteins as shown in Fig. S3 A and specified in the corre-
sponding legend (see also Materials and methods). Means ± SD of three independent experiments; n > 150; **, P < 0.01; ***, P < 0.001; Student’s t test. (E) The 
PS distribution in control and ORP10-KD cells using the C2 domain of lactadherin (C2-Lact-GFP, a marker for PS). Insets: Golgi marker Golgin-97. Scale bar, 10 
µm. Right: Fluorescence intensity ratio of C2-Lact-GFP measured in an equivalent area of the Golgi and the PM in mock and ORP10-KD cells. Data are means 
± SD. n = 50. ***, P < 0.001; Student’s t test. (F and G) Quantification of ERTGoCS in control cells and in ORP10-KD cells untreated or treated with PS (DOPS; 
F), or in cells expressing PS synthase 1 (PTD SS1) in its WT and constitutively active (P269S) forms (G). Means ± SD of three independent experiments; n > 150. 
*, P < 0.05; ***, P < 0.001; Student’s t test. (H) Quantification of ERTGoCS in HeLa cells and in ORP9-KD HeLa cells treated with itraconazole. n > 150; three 
independent experiments. Data are means ± SD. *, P < 0.05; ns, not significant with respect to untreated control cells; Student’s t test.
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insensitive to product inhibition (Sousa et al., 2014; Sohn et al., 
2016; Fig. 5 G and Fig. S3 E).
We addressed the same question (i.e., a structural versus a 
lipid transfer activity-dependent role in maintaining the ERT-
GoCS) for OSBP1, which was found to be an obligate partner 
of ORP9 in maintaining ERTGoCS. To this end, we studied the 
effect of itraconazole, an inhibitor of OSBP1 lipid exchange ac-
tivity (Strating et al., 2015), on the stability of the ERTGoCS and 
found that it had no inhibitory effect either in control cells or in 
ORP9-KD cells (Fig. 5 H).
Discussion
Here, we have reported the development of a FRET–FLIM ap-
proach to visualize the ERTGoCS in their native form (i.e., in the 
absence of contact stabilizers) based on the use of a GFP-fused 
TGN reporter and a cherry-fused ER reporter. While FRET mea-
surements have been previously applied to the study of ER–mito-
chondria contact sites, they were always under conditions where 
they had been stabilized by rapamycin-induced dimerization of 
the organelle reporters (Csordás et al., 2010; Naon et al., 2016).
By coupling FRET–FLIM and EM approaches, we performed 
the first systematic study aimed at identifying molecular deter-
minants of ERTGoCS. Each approach has complementary pros 
and cons. The FRET–FLIM approach enables the exploration of 
multiple conditions, but it provides information that is averaged 
over the Golgi area without reaching single stack resolution. This 
is achieved by EM that is endowed with a very limited throughput 
but provides information on the distribution of ERTGoCS across 
the different stacks, on their extension and “tightness.” Indeed, 
by applying rather strict criteria to the definition of ERTGoCS 
(i.e., sites where the TGN and ER membranes come closer than 
20 nm) we show that the distribution of ERTGoCS across the 
Golgi stacks is not homogeneous, as only a fraction (55%) of 
Golgi stacks is engaged in ERTGoCS, and the TGN area apposed 
to the ER in these stacks accounts on average for 24% of the TGN 
surface. Since the EM provides a snapshot, we cannot presently 
distinguish between two possible scenarios that could account 
for this distribution: either all the stacks have the same likelihood 
to engage in tight contacts with the ER, and at any given time, 
only 55% exhibit ERTGoCS, or there is only a subset of stacks that 
has the ability to contact the ER, thus generating heterogeneity 
among the different Golgi stacks with regard to their closeness 
to the ER. Additionally, there is also heterogeneity in the width 
of ERTGoCS, which ranges from 5 to 20 nm, with 40% of them 
spanning <10 nm.
We have shown that the ERTGoCS require both structural 
tethers and a proper lipid composition of the TGN. We identi-
fied the ER VAP proteins as major determinants of the stability 
of ERTGoCS since their depletion or ablation (by siRNA or by 
TAL EN) abolished the FRET signal and eliminate the ERTGoCS 
as evaluated by EM.
The profound destabilizing effect of VAP depletion/ablation 
can be explained by the role of VAPs as a common ER anchor for 
the different members of the family of lipid transfer proteins act-
ing at the ERTGoCS. These include OSBP1, ORP9, and ORP10. We 
have shown that OSBP1 and ORP9, while “using” the ERTGoCS for 
lipid exchange, can also act as tethers. The higher cellular levels 
of both OSBP1 and ORP9 (244 and 48 nM, respectively; Hein et 
al., 2015) and their higher affinity for VAPs (Mikitova and Levine, 
2012; Murphy and Levine, 2016) and PI4P (Levine and Munro, 
2002) relative to other members of the family may explain why 
they can play a tethering role. This is also in line with previous 
reports showing that OSBP1 can tether liposomes in vitro and, 
when overexpressed (as a WT or transfer-inactive mutant form), 
induces the wrapping of ER membranes around the Golgi com-
plex (Mesmin et al., 2013). However, our data show that OSBP1 
is dispensable for the maintenance of ERTGoCS, since they were 
unaffected in OSBP1-depleted cells. Instead, the combined deple-
tion of OSBP1 and ORP9 is required to disrupt ERTGoCS demon-
strating that they play redundant roles regarding their tethering 
function. The situation is different for ORP10 that is required 
to maintain the ERTGoCS due to its ability to transfer PS from 
the ER to the Golgi, thus indicating that the presence/levels of 
PS at the TGN are involved in the establishment/maintenance 
of the contact through mechanisms and effectors that remain to 
be investigated.
The development of the FRET–FLIM approach to visualize the 
ERTGoCS paves the way for studies that will lead to the identi-
fication of the full repertoire of regulators and constituents of 
ERTGoCS and to an appraisal of the functional consequences of 
their destabilization or stabilization. Thanks to this approach we 
have identified a key role of ERTGoCS in controlling the levels of 
PI4P at the TGN and in acting as a gatekeeper for the TGN export 
of selected cargoes (see Venditti et al. in this issue).
Materials and methods
Reagents and antibodies
Primary antibodies used in this study were mouse monoclo-
nal anti-HA (Covance), rabbit polyclonal anti-ORP9 (Sigma- 
Aldrich), rabbit polyclonal anti-ORP10 (Pierce), rabbit polyclonal 
anti-β actin (Sigma-Aldrich), and sheep polyclonal anti-TGN46 
(Serotec). Rabbit polyclonal antibodies against FAPP1, FAPP2 
(Godi et al., 2004), VAP-A, VAP-B (Jansen et al., 2011), Golgin-97 
(Medina et al., 2015), ORP11, CERT, and OSBP1 were obtained in 
our laboratories.
The following reagents were kind gifts: TGN46-FRB-HA-CFP 
and WT and mutant GFP-PTD SS1 from T. Balla (National In-
stitutes of Health, Bethesda, MD), Venus-Cb5 from N. Borgese 
(Consiglio Nazionale delle Ricerche [CNR], Institute of Neurosci-
ence, Milan, Italy), PH-FFAT-mCherry of OSBP1 from B. Antonny 
(Centre National de la Recherche Scientifique [CNRS], Institut 
de Pharmacologie Moléculaire et Cellulaire, Valbonne, France), 
and TGN38-HRP from D. Cutler (Medical Research Council Lab-
oratory for Molecular Cell Biology, London, UK). The pIRES-
neo2, pmCherry-C3, pmCherry-N1, pEGFP-N1, pEGFP-C3, and 
pEGFP-C1 were purchased from Clontech; p3XFL AG(CMV-14) 
was purchased from Sigma-Aldrich; pGEX-4T2 was purchased 
from GE Healthcare; and C2-Lact-GFP (no. 22852) was pur-
chased from AddGene.
Media, serum, and reagents for tissue culture were pur-
chased from Thermo Fisher Scientific. Unless otherwise stated, 
all chemicals were purchased from Sigma-Aldrich.
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Plasmid construction
All reagents for molecular biology were purchased from New En-
gland Biolabs. All mutagenesis was performed by Site-Directed 
Mutagenesis (Agilent Technologies). The MCS reporter construct 
TGN46-FRB-HA-GFP-T2A-mCherry-FKBP-Cb5-pIRES-neo2 was 
generated by sequential subcloning into the pIRES-neo2 vector 
(see Table S1 for constructs and cloning strategies). Briefly, the 
ER–membrane reporter Cb5 (17 residues of the transmembrane 
domain of rat cytochrome b5 [Bulbarelli et al., 2002], cloned in-
frame downstream of the mCherry-FKBP construct) was cloned 
into pIRES-neo2 followed by in vitro primer annealing of the 
T2A peptide coding sequence (Osborn et al., 2005) to produce 
T2A-mCherry-FKBP-Cb5-IRES-neo2 (note that this cloning 
procedure resulted in the removal of the AgeI restriction site at 
the 3′ end, which was reconstituted at the 5′ end of the T2A se-
quence to allow the sequential cloning of the TGN46 construct). 
The TGN membrane protein TGN46-FRB-HA-GFP (TGN46 fused 
with the FKBP12-rapamycin-binding domain FRB) was generated 
by replacing CFP with GFP in TGN46-FRB-HA-CFP. The resulting 
TGN46-FRB-HA-GFP construct was used as a template for up-
stream cloning into T2A-mCherry-FKBP-Cb5-pIRES-neo2. The 
TGN46-FRB-HA-mCherry-T2A-FKBP-Cb5-pIRES-neo2 plasmid 
(as above but without GFP) was generated similarly by amplify-
ing TGN46-FRB-HA from TGN46-FRB-HA-GFP and cloning into 
T2A-mCherry-FKBP-Cb5-pIRES-neo2.
All the cloning strategies adopted for generating the other 
plasmids used in this study are summarized in Table S1.
Cell culture, transfection, and RNA interference
HeLa cells were grown in high-glucose (4,500 mg/l) DMEM sup-
plemented with 10% FCS. HeLa WT and HeLa VAP-KO cell lines 
were a generous gift from P. De Camilli (Yale University School 
of Medicine, New Haven, CT). VAP-KO cells were generated by a 
TAL EN-based gene-editing approach with TAL EN pairs specific 
to exon 2 of VAPA and VAPB and were cultured as previously de-
scribed (Dong et al., 2016). HeLa cells stably expressing the MCS 
pIRES-neo2 reporter vector were isolated as a clone obtained by 
single cell sorting procedures.
For transfection of DNA plasmids, HeLa cells were transfected 
using JetPEI (Polyplus) as transfection reagent, and the expres-
sion was maintained for 16 h before processing.
siRNA sequences used in this study are listed in Table S2. The 
HeLa cells were treated for 72 h with Oligofectamine (Life Tech-
nologies) for direct transfection. The knockdown efficiency was 
verified by Western blot analysis and is shown in Fig. S4. Cells 
treated with identical concentrations of nontargeting siRNAs 
(D-001810-01-20 and D-001810-02-20; Dharmacon) are referred 
to as controls.
Immunofluorescence analysis
HeLa cells were grown on coverslips and fixed with 4% PFA for 
10 min, washed three times with PBS, blocked, and permeabi-
lized for 30 min with blocking solution (0.05% saponin, 0.5% 
BSA, and 50 mM NH4Cl in PBS) and incubated with primary an-
tibodies diluted in blocking solution for 1 h at RT. Coverslips were 
washed with PBS and incubated with fluorochrome-conjugated 
secondary antibodies (Alexa Fluor 488, Alexa Fluor 568, and 
Alexa Fluor 633) for 1 h at RT. Cells were mounted in Mowiol and 
imaged with a Plan-Apochromat 63×/1.4 oil objective on a Zeiss 
LSM800 or LSM880 confocal system equipped with an Elec-
tronically Switchable Illumination and Detection (ESID) module 
and an AiryScan module (for LSM880) and controlled by a Zen 
blue software. Fluorescence images presented are representative 
of cells imaged in at least three independent experiments and 
were processed with Fiji (ImageJ; National Institutes of Health) 
software. PS distribution (Fig. 5 E) was quantified by perform-
ing the fluorescence intensity ratio of C2-Lact-GFP measured in 
an ROI defining the Golgi area (delimited by the Golgi marker 
Golgin-97) and in an equivalent area on the PM as described in 
the corresponding figure legends. Quantification of ER–Golgi 
contact sites (Fig. 5, D and F–H; and Fig. S3 A) was performed 
as indicated below and in the corresponding figure legends. 
Differences among groups were performed using the unpaired 
Student’s t test calculated with the GraphPad Prism software. All 
data were reported as means ± SEM or SD, as indicated in the 
figure legends.
FRET–FLIM experiments
For FLIM measurements, HeLa cells were seeded on glass-bot-
tom MatTeK dishes. Cells were transfected with the TGN46-FRB-
HA-GFP-T2A-mCherry-FKBP-Cb5-pIRES-neo2 plasmid (Bajar 
et al., 2016). 16 h after transfection, cells were fixed with 1.87% 
paraformaldehyde in 1× PBS for 10 min at RT. To reduce autoflu-
orescence, cells were subsequently incubated with 1× PBS sup-
plemented with 50 mM NH4Cl. The imaging was performed in 
1× PBS, without any mounting agent. Samples were analyzed the 
day of preparation without storage at low temperature (i.e., 4°C).
In a parallel set of experiments, we used a different donor flu-
orophore, Alexa Fluor 430, since the fluorophores Alexa Fluor 
430 and mCherry form a favorable Förster donor–acceptor pair 
with an R0 value (defined as the distance at which 50% of the 
excited donor molecules transfer energy by FRET) of 6.05 nm 
(Scalia and Scheffold, 2015). Alexa Fluor 430 was conjugated to 
anti-HA antibodies (see below) in HeLa cells stably expressing 
TGN46-FRB-HA-T2A-mCherry-FKBP-Cb5-pIRES-neo2.
Fluorescence lifetime images were acquired using a Zeiss 
LSM710 (two-photon) confocal microscope, equipped with a 
FLIM Upgrade kit (Picoquant).
For TGN-GFP detection, the sample was excited using a pulsed 
femtosecond Ti:Sa laser (Chameleon VIS ION 2 from Coherent, 
set at 900 nm) at a fixed repetition rate of 80 MHz. Fluorescence 
signal was spectrally filtered using a narrowband emission filter 
(BP-filter 482/35; Chroma). Photons were collected using a sin-
gle-photon sensitive detector (PMA-Hybrid 40; Picoquant) and 
timed using a single photon counting module (TimeHarp 260; 
Picoquant). FLIM data were background subtracted and pro-
cessed using the pixel-based fitting software SymPhoTime 64 
(Picoquant) to calculate the lifetime maps.
We measured the donor lifetime in ROIs, defined as the pe-
ripheral regions of the TGN46-GFP positive area (Fig. 2 C) where, 
in preliminary experiments, we registered that the donor has 
the lower lifetime suggesting that these were the regions where 
the donor (i.e., TGN) came closer to the acceptor (i.e., ER). The 
analysis of lifetime distribution was limited to pixels with >500 
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total collected photons. Lifetime was determined per single 
thresholded pixel and used to build histograms of lifetime ver-
sus pixel frequency (pixel frequency calculated with reference 
to total pixels of the ROI). The acquired fluorescence decay curve 
was deconvoluted with the instrument response function and 
fitted by a Levenberg–Marquardt least-squares algorithm, using 
the SymphoTime64 software (PicoQuant). Amplitude-weighted 
average lifetime was calculated as τ = Σ(αiτi)/Σαi, where αi is the 
amplitude of each lifetime τi. FRET–FLIM efficiency was calcu-
lated using the equation FRET eff = 1 − (τDA/τD), where τDA is the 
lifetime of the donor in the presence of the acceptor and τD is the 
lifetime of the donor without the acceptor (Llères et al., 2017). 
Validation of the FRET signal in cells expressing TGN46-FRB-
HA-GFP-T2A-mCherry-FKBP-Cb5-pIRES-neo2 was performed 
by photobleaching mCherry-Cb5 in the TGN46-GFP region and 
then measuring FRET–FLIM.
Fluorescence labeling of the monoclonal anti-HA antibody
The monoclonal anti-HA antibody was labeled with the reac-
tive fluorescent probe Alexa Fluor 430 NHS Ester (Succinim-
idyl Ester) purchased from Thermo Fisher Scientific. In brief, 
the antibody was concentrated and dialyzed in reaction buffer 
(0.1 M sodium bicarbonate buffer, pH 8.3). 0.2 mg of antibody 
was mixed with Alexa Fluor 430 with a molar ratio of 12:1 (dye: 
antibody) in a final volume of 0.125 ml and incubated at RT for 
1 h. To remove unreacted fluorescence probe and change buffer, 
the anti-HA–Alexa Fluor 430 complex was purified using a Sep-
hadex G25 column (GE Healthcare) preequilibrated with 20 mM 
sodium phosphate, pH 7.4, and 0.1 M NaCl. 50-µl fractions were 
collected; the absorption spectra between 220 and 600 nm were 
measured; and the degree of labeling was 4, calculated according 
to the manufacturer’s protocol.
Rapamycin-induced stabilization of ERTGoCS in cells 
expressing TGN46-FRB-HA and mCherry-FKBP-Cb5
As shown in Fig. 3 D, brief treatment with low concentrations of 
rapamycin (2 min, 200 nM) of HeLa cells expressing TGN46-FRB-
HA-GFP and mCherry-FKBP-Cb5 induced a marked decrease of 
TGN-GFP lifetime, indicating a stabilization of ERTGoCS.
We observed that as a consequence of ERTGoCS stabilization, 
this rapamycin treatment also induced a peri-Golgi clustering 
of the ER reporter protein Cb5 (Fig. 3 D and Fig. S3 A). Impor-
tantly, the perinuclear clustering induced by 2-min rapamycin 
treatment was largely prevented in ORP10-depleted cells (Fig. S3 
A), indicating that under these mild treatment conditions, rapa-
mycin was stabilizing preexisting physiological ERTGoCS and 
not inducing artificial tethering between the TGN and the ER. 
However, the perinuclear clustering of Cb5 could be restored in 
ORP10-depleted cells by reexpressing an siRNA-resistant form of 
ORP10 (Fig. 5 D and Fig. S3 A) or by elevating PS levels (Fig. 5, F and 
G). To follow the rapamycin-induced stabilization of ERTGoCS, 
HeLa cells expressing TGN46-FRB-HA-GFP-mCherry-FKBP-Cb5 
and treated with the indicated siRNAs were pretreated with 50 
µg/ml cycloheximide for 30 min and then treated with 200 nM 
rapamycin at 37°C for the indicated time points, followed by para-
formaldehyde fixation. Both the cycloheximide and the rapamy-
cin treatments were performed in complete growth medium 
at 37°C. Cells were then stained with the anti-HA antibody (to 
verify TGN46 expression) and with a Golgi marker (Golgin-97 
to check the overall status of the cells). 15–20 individual fields 
were imaged (for a total of 150–200 cells) and analyzed to assess 
mCherry-Cb5 localization. P values were calculated on the basis 
of mean values from at least three independent experiments.
EM and stereological analysis
The EM samples were prepared as previously described (D’Angelo 
et al., 2007). Briefly, cells were fixed by adding to the culture 
medium the same volume of a mixture of PHEM buffer (10 mM 
EGTA, 2 mM MgCl2, 60 mM Pipes, and 25 mM Hepes, pH 6.9), 4% 
PFA, and 2% glutaraldehyde for 2 h and then stored in storage 
solution (PHEM buffer and 0.5% PFA) overnight. After washing 
with 0.15 M glycine buffer in PBS, the cells were scraped and pel-
leted by centrifugation, embedded in 10% gelatin, cooled on ice, 
and cut into 0.5-mm blocks. The blocks were infused with 2.3 M 
sucrose and trimmed with an ultramicrotome (Ultracut R; Leica) 
at −120°C using a dry diamond knife.
For the quantification of ERTGoCS, only the Golgi stacks in 
which both the cis and trans elements were clearly distinguish-
able were considered. In one set of experiments, ERTGoCS were 
quantified in HeLa cells expressing TGN38 conjugated with HRP 
in which the TGN could be identified by the dark DAB reaction 
product (Fig. 1 A). The membranes of the ER were identified by 
the presence of associated ribosomes.
The number of ERTGoCS was quantified using the software 
of a Philips Tecnai-12 electron microscope, considering a contact 
site to be a region where ER and TGN membranes come closer 
than 20 nm for a tract of at least 60 nm. We measured both 
the contact site length, which spanned from 61 to 290 nm, and 
its width, expressed as the mean distance of three segments 
of the contact.
To measure the percentage of the TGN surface in contact with 
the ER, the TGN surface was estimated by using a stereological 
approach (grid intersection counting; Mayhew, 1979; Ferguson 
et al., 2017). Briefly, a grid made of arrays of 50 × 50-nm squares 
was superimposed on each image, and the total intersections 
of ERTGoCS (areas were the distance between TGN and the ER 
membranes is ≤20 nm) and the total intersections of TGN mem-
branes with the test square edges were counted. The ratio be-
tween the two counts is an estimation of the percentage of TGN 
surface engaged in MCSs with the ER.
At the same time, we measured the ratio between the TGN 
surface (calculated as detailed above) and the area of the cyto-
plasm (expressed in square micrometers) to assess whether the 
total TGN area was affected in any of the analyzed conditions. We 
found that this ratio remained constant and similar to the control 
in all the analyzed conditions.
FIB-SEM tomography
The 3D organization of ERTGoCS was analyzed in a Crossbeam 
550 FIB-SEM system operating under SmartSEM and Atlas3D 
software (Zeiss). Epon-embedded cell pellets were first inves-
tigated by TEM to assess the quality and contrast of the speci-
mens. Resin blocks were then mounted on SEM specimen stubs 
and coated with a thin layer of platinum. Trimmed surfaces of 
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Epon blocks were used to find the cells and then to obtain tomo-
graphic datasets with the slice and view technique. Slicing was 
performed using the focused Ga ion beam with each step remov-
ing 15 nm of the Epon-embedded material. The SEM images were 
recorded with an EsB detector at 5 × 5-nm pixel size. The contrast 
of the images was inverted so that they appeared like a conven-
tional brightfield TEM image. Serial FIB-SEM images were im-
ported into open-source ImageJ software to generate QuickTime 
movies and annotations (Video 1).
PS-affinity isolation of subcellular fractions
The HeLa cells (control and ORP10-KD cells) were broken in hypo-
tonic buffer (10 mM Tris HCl, pH 7.4, and 1.5 mM MgCl2) containing 
1 mM DTT and protease inhibitors using a cell cracker apparatus 
(at a clearance of 8 µm). Cell lysates were diluted 1:2 in incubation 
buffer (final concentration, 40 mM Tris HCl, pH 7.4, 80 mM NaCl, 
70 mM KCl, 250 mM sorbitol, 1 mM EDTA, 1 mM MgCl2, 1 mM DTT, 
and protease inhibitors) and clarified by centrifugation at 1,500 
×g for 10 min at 4°C. The supernatants (1.6 mg ml−1) were prein-
cubated with 0.1 µM GST-LacC2 domain or with 0.1 µM GST for 
5 h at 4°C and then incubated with Glutathione Magnetic Agarose 
Beads (Pierce; 25 µl beads for 500 µl cell lysate) for 1 h at 4°C. After 
six washes with incubation buffer (without sorbitol and with 
0.0005% Tween 20) the beads were treated with Laemmli sample 
buffer, and the eluted fractions were analyzed by SDS-PAGE and 
Western blot with antibodies against a TGN marker (TGN46). The 
ratio between the TGN46 signal in the eluted fractions and that in 
the input was calculated in control and ORP10-KD samples, and 
the results were expressed as a percentage of the control.
Online supplemental material
Fig. S1 shows the validation of the FRET–FLIM approach to vi-
sualize ERTGoCS. Fig. S2 shows the morphometric analysis of 
ERTGoCS in cells depleted of lipid transfer proteins found to be 
dispensable for ERTGoCS integrity by FRET–FLIM. Fig. S3 shows 
how ORP10 controls PS levels at the TGN. Fig. S4 shows the ef-
fect of siRNAs used in the study on target protein levels. Table S1 
shows a list of primers and cloning strategies used in this study. 
Table S2 shows the list of siRNA sequences used in this study. 
Video 1 shows the FIB-SEM analysis of ERTGoCS.
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